Inventor
MUNDT CORNELIA ANNE
DE21 patents
⚠️ This page may combine multiple inventors who share the name “MUNDT CORNELIA ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENUS INC
19 patentsUS10144779B2Dec 4, 2018
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC12 citations92
US11638755B2May 2, 2023
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC4 citations84
US11242385B2Feb 8, 2022
Anti-CD137 antibodies and methods of use thereof
AGENUS INC8 citations84
US10479833B2Nov 19, 2019
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC8 citations84
US10323091B2Jun 18, 2019
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC5 citations83
US11013802B2May 25, 2021
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC5 citations82
US10912831B1Feb 9, 2021
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC6 citations82
US11267889B2Mar 8, 2022
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC2 citations73
US11345755B2May 31, 2022
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC2 citations72
US11993653B2May 28, 2024
Antibodies and methods of use thereof
AGENUS INC2 citations71
US10882908B2Jan 5, 2021
Anti-LAG-3 antibodies and methods of use thereof
AGENUS INC2 citations71
US10844119B2Nov 24, 2020
Anti-LAG-3 antibodies and methods of use thereof
AGENUS INC3 citations71
US12492257B2Dec 9, 2025
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC0 citations62
US12492393B2Dec 9, 2025
Anti-CD137 antibodies and methods of use thereof
AGENUS INC0 citations61
US12246066B2Mar 11, 2025
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC0 citations61
US12187795B2Jan 7, 2025
Anti-LAG-3 antibodies and methods of use thereof
AGENUS INC0 citations61
US11993651B2May 28, 2024
Anti-lag-3 antibodies and methods of use thereof
AGENUS INC0 citations61
US11098117B2Aug 24, 2021
Anti-CD137 antibodies and methods of use thereof
AGENUS INC0 citations61
US10450373B2Oct 22, 2019
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC0 citations51